Mesa Laboratories Inc
NASDAQ:MLAB
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
84.94
140.86
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Mesa Laboratories Inc
Wall Street
Price Targets
MLAB Price Targets Summary
Mesa Laboratories Inc
According to Wall Street analysts, the average 1-year price target for
MLAB
is 142.8 USD
with a low forecast of 121.2 USD and a high forecast of 157.5 USD.
MLAB Last Price Targets
Mesa Laboratories Inc
The latest public price target was made on Aug 27, 2024 by
Brandon Couillard
from
Wells Fargo
,
who expects
MLAB
stock to
rise by 10%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Brandon Couillard
Wells Fargo
|
120
USD
Upside 10% |
2 months ago
Aug 27, 2024
|
Mesa Labs initiated with an Underweight at Wells Fargo
TheFly
|
Vijay Kumar
Evercore ISI
|
120
USD
Upside 10% |
5 months ago
Jun 7, 2024
|
Evercore ISI Removes Mesa Laboratories (MLAB) from TAP List
StreetInsider
|
Operating Income
Forecast
Operating Income Estimate
Mesa Laboratories Inc
For the last 8 years the
compound annual growth rate for
Mesa Laboratories Inc's operating income is
-21%.
The projected
CAGR
for the next 3 years is
132%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MLAB's stock price target?
Price Target
142.8
USD
According to Wall Street analysts, the average 1-year price target for
MLAB
is 142.8 USD
with a low forecast of 121.2 USD and a high forecast of 157.5 USD.
What is Mesa Laboratories Inc's Revenue forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
Mesa Laboratories Inc's revenue is
12%.
The projected
CAGR
for the next 3 years is
8%.
What is Mesa Laboratories Inc's Operating Income forecast?
Projected CAGR
132%
For the last 8 years the
compound annual growth rate for
Mesa Laboratories Inc's operating income is
-21%.
The projected
CAGR
for the next 3 years is
132%.
You don't have any saved screeners yet
